AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Sale
+$3,807,102
-92.14%
Shares
Shares Volume: 3,525,094 Shares
Average Share Price: $1.08
INSIDER
RA CAPITAL MANAGEMENT, L.P.
(10% Owner)
reported on Aug 13 2024
traded on Aug 9 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 300,853 |
| PURCHASES/SALES 1Y | 1 / 1 |
| P/S VALUE RATIO | 4.203 |
| AVERAGE SALE VALUE | $3,807,101.52 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 1 / 37 |
| P/S VALUE RATIO | 1.141 |
| AVERAGE SALE VALUE | $378,966.3 |
| COMPANY PREVIOUS TRADES |